Scientists at University of California San Diego have developed a new approach to destroying cancer stem cells—hard-to-find ...
EPFL researchers have uncovered how transcription factor dosage reshapes cell identity, showing that even small differences ...
Study findings suggest using the drug PF-06409577 to restore CDX2 in colon cancers could cut risk of recurrence and death by up to 50%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback